Standard Biotools (LAB) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.11% |
| Dec 31, 2025 | 93.17% |
| Sep 30, 2025 | 103.03% |
| Jun 30, 2025 | 137.14% |
| Mar 31, 2025 | 173.94% |
| Dec 31, 2024 | 70.85% |
| Sep 30, 2024 | 70.15% |
| Jun 30, 2024 | 67.05% |
| Mar 31, 2024 | 67.46% |
| Dec 31, 2023 | -45.25% |
| Sep 30, 2023 | -42.06% |
| Jun 30, 2023 | -41.85% |
| Mar 31, 2023 | -39.02% |
| Dec 31, 2022 | -36.27% |
| Sep 30, 2022 | -33.62% |
| Jun 30, 2022 | -30.39% |
| Mar 31, 2022 | -50.49% |
| Dec 31, 2021 | 9.47% |
| Sep 30, 2021 | 64.26% |
| Jun 30, 2021 | 46.47% |
| Mar 31, 2021 | 36.28% |
| Dec 31, 2020 | 65.03% |
| Sep 30, 2020 | 57.27% |
| Jun 30, 2020 | 491.37% |
| Mar 31, 2020 | 482.03% |
| Dec 31, 2019 | 42.37% |
| Sep 30, 2019 | 33.74% |
| Jun 30, 2019 | 487.92% |
| Mar 31, 2019 | 492.43% |
| Dec 31, 2018 | -14.38% |
| Sep 30, 2018 | -43.48% |
| Jun 30, 2018 | -36.06% |
| Mar 31, 2018 | -30.14% |
| Dec 31, 2017 | -40.97% |
| Sep 30, 2017 | -36.77% |
| Jun 30, 2017 | -26.08% |
| Mar 31, 2017 | -26.08% |
| Dec 31, 2016 | -17.96% |
| Sep 30, 2016 | -11.18% |
| Jun 30, 2016 | -26.17% |
| Mar 31, 2016 | -26.18% |
| Dec 31, 2015 | 4.51% |
| Sep 30, 2015 | 6.53% |
| Jun 30, 2015 | 39.64% |
| Mar 31, 2015 | 40.01% |
| Dec 31, 2014 | 38.27% |
| Sep 30, 2014 | 37.73% |
| Jun 30, 2014 | 37.46% |
| Dec 31, 2013 | 35.90% |